In nasopharyngeal carcinoma cells, ARHGEF3 inhibits apoptosis by regulating the expression of ILP-2, which in turn inhibits the activation of caspases-3. This evidence concerns the gene ARHGEF3 and nasopharyngeal carcinoma.